Capital Farma is a leading European pharmaceutical company founded in 2022, focusing on the development and distribution of niche products and services for generic laboratories worldwide. The company is dedicated to reinforcing and strengthening laboratory supply chains by providing a wide range of active pharmaceutical ingredients (APIs) from different origins. Capital Farma acts to accelerate European re-industrialisation by offering advanced technology and superior distribution capabilities.

Services include:
– Biologics
– Contract Manufacturing Organisation (CMO)
– Contract Development and Manufacturing Organisation (CDMO)
– Distribution of APIs
– Custom synthesis

Capital Farma is committed to supporting the pharmaceutical industry with its comprehensive range of services. For more information, visit capitalfarma.com.